{"id":"W4317931233","title":"Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders <i>v.</i> treatment as usual: economic evaluation of a pragmatic randomized controlled trial over an 8-month time horizon using self-reported data","authors":["Alexandra Chapdelaine","Helen‚ÄêMaria Vasiliadis","Martin D. Provencher","Peter J. Norton","Pasquale Roberge"],"venue":"Psychological Medicine","year":2023,"doi":"10.1017/s0033291722003920","url":"https://doi.org/10.1017/s0033291722003920","openalex":"https://openalex.org/W4317931233","abstract":"Abstract Background This economic evaluation supplements a pragmatic randomized controlled trial conducted in community care settings, which showed superior improvement in the symptoms of adults with anxiety disorders who received 12 sessions of transdiagnostic cognitive-behavioural group therapy in addition to treatment as usual (tCBT + TAU) compared to TAU alone. Methods This study evaluates the cost-utility and cost-effectiveness of tCBT + TAU over an 8-month time horizon. For the reference case, quality-adjusted life years (QALYs) obtained using the EQ-5D-5L, and the health system perspective were chosen. Alternatively, anxiety-free days (AFDs), derived from the Beck Anxiety Inventory, and the limited societal perspective were considered. Unadjusted incremental cost-effectiveness/utility ratios were calculated. Net-benefit regressions were done for a willingness-to-pay (WTP) thresholds range to build cost-effectiveness acceptability curves (CEAC). Sensitivity analyses were included. Results Compared to TAU ( n = 114), tCBT + TAU ( n = 117) generated additional QALYs, AFDs, and higher mental health care costs from the health system perspective. From the health system and the limited societal perspectives, at a WTP of Can$ 50 000/QALY, the CEACs showed that the probability of tCBT + TAU v. TAU being cost-effective was 97 and 89%. Promising cost-effectiveness results using AFDs are also presented. The participation of therapists from the public health sector could increase cost-effectiveness. Conclusions From the limited societal and health system perspectives, this first economic evaluation of tCBT shows favourable cost-effectiveness results at a WTP threshold of Can$ 50 000/QALY. Future research is needed to replicate findings in longer follow-up studies and different health system contexts to better inform decision-makers for a full-scale implementation.","is_oa":true,"oa_status":null,"network":{"internal_citations":3,"cited_by_count":8},"references":78,"networkCitations":3,"seed":false}